Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Langer

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
American Heart Journal|August 10, 2010
Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate riskAlessandra Boscheri, Carsten Wunderlich, Martin Langer, et al.
Glycobiology|July 30, 2002
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosidesJohannes Müthing, Monika Burg, Babette Möckel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2004
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscuminJohannes Müthing, Iris Meisen, Bernhard Kniep, et al.
Tumori|December 2, 2017
Thirty-day mortality and five-year survival in thoracic surgery: "real-world" assessment of outcomes from a single-institution auditAnna Cantarutti, Carlotta Galeone, Giovanni Leuzzi, et al.
Intensive Care Medicine|August 1, 2018
Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West AfricaMartin Langer, Gina Portella, Stefano Finazzi, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Rates and Determinants of Hospital-Acquired Infection among ICU Patients Undergoing Cardiac Surgery in Developing Countries: Results from EMERGENCY'NGO's Hospital in SudanOrnella Spagnolello, Silvia Fabris, Gina Portella, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 25, 2010
Consensus document on controversial issues for the treatment of hospital-associated pneumoniaFabio Franzetti, Massimo Antonelli, Matteo Bassetti, et al.
Interactive Cardiovascular and Thoracic Surgery|August 26, 2022
Simple open-heart surgery protocol for sickle-cell disease patients: a retrospective cohort study comparing patients undergoing mitral valve surgeryFrancesco Epis, Liliane Chatenoud, Alberto Somaschini, et al.
Journal of Orthopaedic Translation|June 4, 2020
Microsurgical reconstruction affects the outcome in a translational mouse model for Achilles tendon healingPhilipp A Michel, Daniel Kronenberg, Gertje Neu, et al.
Intensive Care Medicine|September 27, 2018
Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection, Guido Bertolini, Giovanni Nattino, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
American Heart Journal|August 10, 2010
Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate riskAlessandra Boscheri, Carsten Wunderlich, Martin Langer, et al.
Glycobiology|July 30, 2002
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosidesJohannes Müthing, Monika Burg, Babette Möckel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2004
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscuminJohannes Müthing, Iris Meisen, Bernhard Kniep, et al.
Tumori|December 2, 2017
Thirty-day mortality and five-year survival in thoracic surgery: "real-world" assessment of outcomes from a single-institution auditAnna Cantarutti, Carlotta Galeone, Giovanni Leuzzi, et al.
Intensive Care Medicine|August 1, 2018
Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West AfricaMartin Langer, Gina Portella, Stefano Finazzi, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Rates and Determinants of Hospital-Acquired Infection among ICU Patients Undergoing Cardiac Surgery in Developing Countries: Results from EMERGENCY'NGO's Hospital in SudanOrnella Spagnolello, Silvia Fabris, Gina Portella, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 25, 2010
Consensus document on controversial issues for the treatment of hospital-associated pneumoniaFabio Franzetti, Massimo Antonelli, Matteo Bassetti, et al.
Interactive Cardiovascular and Thoracic Surgery|August 26, 2022
Simple open-heart surgery protocol for sickle-cell disease patients: a retrospective cohort study comparing patients undergoing mitral valve surgeryFrancesco Epis, Liliane Chatenoud, Alberto Somaschini, et al.
Journal of Orthopaedic Translation|June 4, 2020
Microsurgical reconstruction affects the outcome in a translational mouse model for Achilles tendon healingPhilipp A Michel, Daniel Kronenberg, Gertje Neu, et al.
Intensive Care Medicine|September 27, 2018
Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection, Guido Bertolini, Giovanni Nattino, et al.
Pageof 10